1.Use of Drug-eluting Stents Versus Bare-metal Stents in Korea: A Cost-minimization Analysis Using Population Data.
Hae Sun SUH ; Hyun Jin SONG ; Eun Jin JANG ; Jung Sun KIM ; Donghoon CHOI ; Sang Moo LEE
Journal of Preventive Medicine and Public Health 2013;46(4):201-209
OBJECTIVES: The goal of this study was to perform an economic analysis of a primary stenting with drug-eluting stents (DES) compared with bare-metal stents (BMS) in patients with acute myocardial infarction (AMI) admitted through an emergency room (ER) visit in Korea using population-based data. METHODS: We employed a cost-minimization method using a decision analytic model with a two-year time period. Model probabilities and costs were obtained from a published systematic review and population-based data from which a retrospective database analysis of the national reimbursement database of Health Insurance Review and Assessment covering 2006 through 2010 was performed. Uncertainty was evaluated using one-way sensitivity analyses and probabilistic sensitivity analyses. RESULTS: Among 513 979 cases with AMI during 2007 and 2008, 24 742 cases underwent stenting procedures and 20 320 patients admitted through an ER visit with primary stenting were identified in the base model. The transition probabilities of DES-to-DES, DES-to-BMS, DES-to-coronary artery bypass graft, and DES-to-balloon were 59.7%, 0.6%, 4.3%, and 35.3%, respectively, among these patients. The average two-year costs of DES and BMS in 2011 Korean won were 11 065 528 won/person and 9 647 647 won/person, respectively. DES resulted in higher costs than BMS by 1 417 882 won/person. The model was highly sensitive to the probability and costs of having no revascularization. CONCLUSIONS: Primary stenting with BMS for AMI with an ER visit was shown to be a cost-saving procedure compared with DES in Korea. Caution is needed when applying this finding to patients with a higher level of severity in health status.
Drug-Eluting Stents/*economics
;
Emergency Service, Hospital/economics
;
Female
;
Humans
;
Male
;
Metals
;
Middle Aged
;
Myocardial Infarction/economics/*therapy
;
Republic of Korea
;
Retrospective Studies
;
Stents/*economics
2.Cost-Effectiveness of Drug-Eluting vs. Bare-Metal Stents in Patients with Coronary Artery Disease from the Korean National Health Insurance Database.
Soojin LEE ; Kyungwon BAEK ; Kihong CHUN
Yonsei Medical Journal 2014;55(6):1533-1541
PURPOSE: The aim of this study was to evaluate the cost-effectiveness of the use of drug-eluting stents (DESs), as compared with bare-metal stents (BMSs) in Korea. MATERIALS AND METHODS: A retrospective cohort study was conducted between January 2000 and December 2007. Subjects were stent-treated for the first time between 2004 and 2005, with four years of follow-up (2004-2007) (n=43674). The incremental cost-effectiveness ratio (ICER) was used to calculate the costs of DESs compared with BMSs among patients with coronary artery disease (CAD). Cost-effectiveness was assessed with effectiveness defined as a reduction in major adverse cardiac events after six months and after one, two, three, and four years. RESULTS: The total costs of a DESs were 674108 Korean won (KRW) higher than that of a BMSs at the end of the follow-up; 13635 thousand KRW per patient treated with DESs and 12960 thousand KRW per patient treated with BMSs. The ICER was 256315 per KRW/death avoided and 293090 per KRW/re-stenting avoided among the CAD patients at the end of the follow-up. CONCLUSION: The ICER for the high-risk patients was lower than that for the low-risk patients. The use of DESs is clinically more useful than the use of BMSs for CAD and myocardial infarction patients, especially for those considered to be high-risk patients in Korea.
Aged
;
*Angioplasty, Balloon, Coronary
;
Asian Continental Ancestry Group/statistics & numerical data
;
Coronary Artery Disease/etiology/*therapy
;
Cost-Benefit Analysis
;
Drug-Eluting Stents/economics
;
Female
;
Humans
;
Immunosuppressive Agents/administration & dosage/*economics
;
Male
;
Middle Aged
;
Myocardial Infarction/therapy
;
National Health Programs/*statistics & numerical data
;
Paclitaxel/administration & dosage
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Risk
;
Sirolimus/administration & dosage
;
Stents/adverse effects/*economics
;
Treatment Outcome
3.The Association of Socioeconomic Status with Three-Year Clinical Outcomes in Patients with Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention.
Jeong Hun KIM ; Myung Ho JEONG ; In Hyae PARK ; Jin Soo CHOI ; Jung Ae RHEE ; Doo Hwan LEE ; Soo Hwan PARK ; In Soo KIM ; Hae Chang JEONG ; Jae Yeong CHO ; Soo Young JANG ; Ki hong LEE ; Keun Ho PARK ; Doo Sun SIM ; Kye Hun KIM ; Young Joon HONG ; Hyung Wook PARK ; Ju Han KIM ; Youngkeun AHN ; Jeong Gwan CHO ; Jong Chun PARK
Journal of Korean Medical Science 2014;29(4):536-543
The aim of this study was to evaluate whether the clinical outcomes were associated with socioeconomic status (SES) in patients with acute myocardial infarction (AMI) who underwent percutaneous coronary intervention (PCI). The author analyzed 2,358 patients (64.9 +/- 12.3 yr old, 71.5% male) hospitalized with AMI between November 2005 and June 2010. SES was measured by the self-reported education (years of schooling), the residential address (social deprivation index), and the national health insurance status (medical aid beneficiaries). Sequential multivariable modeling assessed the relationship of SES factors with 3-yr major adverse cardiovascular events (MACEs) and mortality after the adjustment for demographic and clinical factors. During the 3-yr follow-up, 630 (26.7%) MACEs and 322 (13.7%) all-cause deaths occurred in 2,358 patients. In multivariate Cox proportional hazards regression modeling, the only lower education of SES variables was associated with MACEs (hazard ratio [HR], 1.41; 95% confidence interval [CI], 1.04-1.91) and mortality (HR, 1.93; 95% CI, 1.16-3.20) in the patients with AMI who underwent PCI. The study results indicate that the lower education is a significant associated factor to increased poor clinical outcomes in patients with AMI who underwent PCI.
Acute Disease
;
Age Factors
;
Aged
;
*Angioplasty, Balloon, Coronary
;
Cohort Studies
;
Demography
;
Female
;
Follow-Up Studies
;
Humans
;
Male
;
Middle Aged
;
Myocardial Infarction/economics/mortality/*therapy
;
*Percutaneous Coronary Intervention
;
Proportional Hazards Models
;
Retrospective Studies
;
Risk Factors
;
Sex Factors
;
Social Class
;
Socioeconomic Factors
;
Treatment Outcome